What's happening
This bill adds xylazine to New York's list of controlled substances, except for federally approved veterinary use, and sets penalties for misuse.
Why it matters
Targets illicit use of xylazine in humans, addressing a growing concern about its role in drug overdoses and its combination with opioids in street drugs, which can increase risks of fatal outcomes.
Preserves legal access for veterinarians and livestock owners by exempting FDA-approved veterinary xylazine, acknowledging its legitimate medical use in nonhuman species and aiming to avoid disrupting animal care.
Imposes criminal penalties on anyone who knowingly misuses xylazine for human consumption, signaling a stricter approach to emerging synthetic drug threats and aligning state law with efforts to curb drug-related harm.
May affect how law enforcement and health professionals monitor and respond to xylazine-involved incidents, potentially improving data collection, public health responses, and resource allocation for overdose prevention.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Veterinarians and livestock owners
The bill would exempt FDA-approved xylazine products intended solely for injection into cattle or other nonhuman species from its controlled-substance restrictions.
People who use xylazine
The bill would classify xylazine as a Schedule I depressant and subject knowing and willful self-administration of exempt animal products intended for human consumption to penalties.
Prescribers and drug distributors
The bill would subject those who knowingly and willfully prescribe, dispense or distribute exempt xylazine products for human consumption or purposes other than animal injection to controlled-substance penalties.
Headline styles
Add Xylazine to Controlled Substances
Plain English, a few words. Used as the page title.
Sponsors
History
- Print number 7763b
- Amend and recommit to health
- Notice of committee consideration - requested
- Print number 7763a
- Amend and recommit to health
- Referred to health
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Add Xylazine to Controlled List
In Assembly Committee · Health · Sponsor Steve Stern
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7763--B
2023-2024 Regular Sessions
IN SENATE
November 17, 2023
Introduced by Sens. MURRAY, ASHBY, BORRELLO, CANZONERI-FITZPATRICK, GALLIVAN, HELMING, MARTINEZ, MARTINS, MATTERA, PALUMBO, RHOADS, TEDIS- CO, WEBER, WEIK -- read twice and ordered printed, and when printed to be committed to the Committee on Rules -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to adding xylazine to the depressants designated as controlled substances
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 1 of section 3305 of the public health law is amended by adding a new paragraph (e) to read as follows:
(e) to any individual who possesses, sells, administers, prescribes, or distributes any substance containing xylazine expressly intended for administration through injections to cattle or other nonhuman species and that are approved by the federal food and drug administration solely for such use.
§ 2. Subdivision (e) of schedule I of section 3306 of the public health law is amended by adding a new paragraph 7 to read as follows:
(7) Xylazine (N- (2, 6-dimethylphenyl) - 5, 6-dihydro-4H-1,3 thiazin- 2-a-mine). This subdivision shall not include any substance containing xylazine expressly intended for administration through injections to cattle or other nonhuman species and that are approved by the federal food and drug administration. Any individual who knowingly and willfully administers to themself or another person, prescribes, dispenses or distributes such substances when any such substance is intended for human consumption or for any purpose other than injection to cattle or nonhuman species shall be subject to the same penalties as any individual or practitioner who violates the provisions of this section, section
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13520-05-4
thirty-three hundred four of this title, or any other penalties prescribed by law.
§ 3. This act shall take effect on the thirtieth day after it shall have become a law.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to adding xylazine to the depressants designated as controlled substances
Purpose
This bill would designate Xylazine as a schedule I depressant outlawing its possession and use; makes an exception when it is being administered and/or prescribed by veterinarians for treating animals.
Summary of provisions
Section one of the bill amends section 3305 of the public health law adding a new paragraph (e) to specify that the possession and use of Xylazine is illegal with an exception for its use only in veterinary practice for purposes of injection to cattle and nonhuman species when such purposes are approved by the federal food and drug administration.
Section two of the bill amends Subdivision (e) of schedule I of section 3306 of the public health law by adding a new paragraph 7 to add Xyla- zine to the list of depressants that are designated as controlled substances when any such substance is intended for human consumption. There is an exemption provided for in this paragraph for its use for cattle and other nonhuman species but only when prescribed for such use by a veterinarian.
Section three of the bill provides the effective date.
Justification
In recent years, there has been an alarming increase of illicit use of the depressant Xylazine, commonly called "tranq" by drug dealers and drug users on the streets. Xylazine has long been appropriately prescribed and administered by veterinarians in a liquid form for treat- ing a number of serious animal health conditions. However, the illicit use of the powder form of "tranq" has grown dangerously as it is frequently being added as a "cutting agent" to fentanyl, heroin and other harmful street drugs. When it is mixed with these drugs the effects are often deadly, due to the fact that it has a severely high depressant effect on the human body's central nervous system.
According to the New York State Department of Health (DOH), "Xylazine is a central nervous system depressant that can cause drowsiness, amnesia, and slow breathing, heart rate, and blood pressure at dangerously low levels. At very high doses, or with other central nervous system depres- sants, xylazine can cause: loss of physical sensation, loss of consciousness, and intensification of the effects of other drugs, which can complicate overdose presentation and treatment." DOH also indicated that where studies across the country have looked at this recently, findings show that, "overdose deaths involving xylazine rose nearly 20-fold between 2015 and 2020." (Source: Xylazine: What Clinicians Need to Know (nv.gov))
Law enforcement entities in NY have noted increasingly alarming trends of Xylazine appearing in toxicology reports from drug overdoses. Howev- er, because the sale and possession of Xylazine in New York state is neither restricted nor illegal in any way, there is no way to prevent drug dealers from adding the potentially deadly substance Xylazine to illicit street drugs.
This change in law is urgently needed to reduce drug overdose deaths and to combat the irreparable harm from use of Xylazine's "tranq" form that currently is unrestricted and easily available as a cutting agent to dangerous street drugs. This bill would enact a badly needed update to our laws to address current drug epidemic problems.
Legislative history
This is a new bill.
Fiscal implications
None.
Effective date
This act shall take effect on the thirtieth day after it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.